Home » Topics » BioWorld Science

BioWorld Science
RSS

Cabo as next annual shot?

May 8, 2020

Antibiotics affect oxycodone effects

May 8, 2020

FDA clears new phase I study of NBTXR-3 activated by radiation therapy for pancreatic cancer

May 7, 2020

FDA approves Tabrecta for metastatic NSCLC with METex14

May 7, 2020

Enanta reports topline phase II data on EDP-305 in primary biliary cholangitis

May 7, 2020

FDA approves Elyxyb for acute treatment of migraine with or without aura

May 7, 2020

Lineage Cell Therapeutics updates phase I/IIa results with OpRegen for dry AMD

May 7, 2020

HIF-1alpha stabilizer GB-004 well tolerated in multiple-dose phase I study

May 7, 2020

DongWha Pharm plans phase II evaluation of DW-2008 for COVID-19

May 7, 2020

New phase III study evaluates lenzilumab in hospitalized patients with COVID-19

May 7, 2020

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...